Insider Trading & Ownership - Bolte Axel

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Bolte Axel
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-19
Purchase
2022-04-20
4:05 pm
Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer
67,750$3.69$249,998258,575
(Direct)
View
2021-06-24
Sale
2021-06-25
07:58 am
Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer
66,788$0.0001$7291,305
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-18
Option Award
2024-06-20
4:09 pm
N/A
2034-06-17
Inozyme Pharma Inc.INZYBolte Axel
Director
28,000$028,000
(Direct)
View
2023-07-11
Disposition
2023-07-13
1:55 pm
N/A
N/A
IVERIC bio Inc.ISEEBolte Axel
Director
132,274$00
(Direct)
View
2023-06-13
Option Award
2023-06-15
4:05 pm
N/A
2033-06-12
Inozyme Pharma Inc.INZYBolte Axel
Director
16,000$016,000
(Direct)
View
2023-05-17
Option Award
2023-05-19
5:55 pm
N/A
N/A
IVERIC bio Inc.ISEEBolte Axel
Director
7,500$07,500
(Direct)
View
2023-05-11
Exercise
2023-05-15
4:51 pm
N/A
N/A
IVERIC bio Inc.ISEEBolte Axel
Director
14,588$022,088
(Direct)
View
2023-05-01
Option Award
2023-05-03
08:40 am
N/A
2033-04-30
Inozyme Pharma Inc.INZYBolte Axel
Director
100,000$0100,000
(Direct)
View
2023-03-31
Option Award
2023-04-04
08:40 am
N/A
N/A
Inozyme Pharma Inc.INZYBolte Axel
Director
4,806$2.21266,696
(Direct)
View
2022-09-30
Option Award
2022-10-04
08:00 am
N/A
N/A
Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer
3,315$2.28261,890
(Direct)
View
2022-05-11
Exercise
2022-05-13
6:05 pm
N/A
N/A
IVERIC bio Inc.ISEEBolte Axel
Director
7,500$045,274
(Direct)
View
2022-05-12
Option Award
2022-05-13
6:05 pm
N/A
N/A
IVERIC bio Inc.ISEEBolte Axel
Director
37,774$045,274
(Direct)
View
2022-02-24
Option Award
2022-02-28
07:47 am
N/A
2032-02-23
Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer
275,000$0275,000
(Direct)
View
2021-06-24
Exercise
2021-06-25
07:58 am
N/A
N/A
Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer
66,788$0.98291,305
(Direct)
View
2021-06-24
Exercise
2021-06-25
07:58 am
N/A
2027-06-27
Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer
66,788$0291,305
(Direct)
View
2021-05-19
Option Award
2021-05-20
7:51 pm
N/A
2031-05-18
IVERIC bio Inc.ISEEBolte Axel
Director
23,000$023,000
(Direct)
View
2021-03-04
Option Award
2021-03-17
5:56 pm
N/A
2031-03-03
Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer
117,000$0117,000
(Direct)
View
2021-01-13
Option Award
2021-01-14
4:14 pm
N/A
2030-04-22
Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer
225,975$0225,975
(Direct)
View
2020-07-23
Option Award
2020-07-24
4:48 pm
N/A
2030-07-22
Inozyme Pharma Inc.INZYBolte Axel
See Remarks
10% Owner
287,706$0287,706
(Direct)
View

Ownership
2020-07-23
9:20 pm
N/A
N/A
Inozyme Pharma Inc.INZYBolte Axel
See Remarks
10% Owner
0$0649,019
(Direct)
View
2020-06-09
Option Award
2020-06-11
2:02 pm
N/A
N/A
IVERIC bio Inc.ISEEBolte Axel
Director
16,000$016,000
(Direct)
View